These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17700016)

  • 41. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).
    O'Keefe JH; Carter MD; Lavie CJ; Bell DS
    Postgrad Med; 2009 May; 121(3):113-8. PubMed ID: 19491548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2006 Oct; 24(30):4808-17. PubMed ID: 17001070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
    Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
    Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
    Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
    Morrissey RP; Diamond GA; Kaul S
    J Am Coll Cardiol; 2009 Oct; 54(15):1425-33. PubMed ID: 19796735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort.
    Poli A; Tragni E; Casula M; Filippi A; Diotti R; Brignoli O; Cricelli C; Catapano AL;
    Nutr Metab Cardiovasc Dis; 2012 Apr; 22(4):327-36. PubMed ID: 20884190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
    Chodick G; Shalev V
    Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
    [No Abstract]   [Full Text] [Related]  

  • 51. Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein lowering.
    Sniderman A; Thanassoulis G; Couture P; Williams K; Alam A; Furberg CD
    J Clin Lipidol; 2012; 6(4):303-9. PubMed ID: 22836065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins in the treatment of chronic heart failure: biological and clinical considerations.
    van der Harst P; Voors AA; van Gilst WH; Böhm M; van Veldhuisen DJ
    Cardiovasc Res; 2006 Aug; 71(3):443-54. PubMed ID: 16730683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of statin dosing intensity on transaminase and creatine kinase.
    Dale KM; White CM; Henyan NN; Kluger J; Coleman CI
    Am J Med; 2007 Aug; 120(8):706-12. PubMed ID: 17679130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statins moderate coronary stenoses but not coronary calcification: results from meta-analyses.
    Henein MY; Owen A
    Int J Cardiol; 2011 Nov; 153(1):31-5. PubMed ID: 20843566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluvastatin treatment is not associated with an increased incidence of cancer.
    Stein EA; Corsini A; Gimpelewicz CR; Bortolini M; Gil M
    Int J Clin Pract; 2006 Sep; 60(9):1028-34. PubMed ID: 16939542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are we lowering LDL cholesterol sufficiently?
    Barter P; Rye KA
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term efficacy and safety of statin treatment beyond six years: a meta-analysis of randomized controlled trials with extended follow-up.
    Lv HL; Jin DM; Liu M; Liu YM; Wang JF; Geng DF
    Pharmacol Res; 2014 Mar; 81():64-73. PubMed ID: 24602799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials.
    Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
    Atherosclerosis; 2018 Apr; 271():223-231. PubMed ID: 29524865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis.
    Sun H; Yuan Y; Wang P; Cai R; Xia W; Huang R; Wang S
    Lipids Health Dis; 2015 Nov; 14():140. PubMed ID: 26526340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limit to benefits of large reductions in low-density lipoprotein cholesterol levels: use of fractional polynomials to assess the effect of low-density lipoprotein cholesterol level reduction in metaregression of large statin randomized trials.
    Takagi H; Umemoto T;
    JAMA Intern Med; 2013 Jun; 173(11):1028-9. PubMed ID: 23700132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.